NIH Funds $3.2 Million Study on the Combination of Immune Blockade and Antiangiogenic Agents in Cancer Treatment - OncoDaily NIH Funds $3.2 Million Study on the Combination of Immune Blockade and Antiangiogenic Agents in Cancer Treatment / antiangiogenic agents, cancer, Immune

NIH Funds $3.2 Million Study on the Combination of Immune Blockade and Antiangiogenic Agents in Cancer Treatment

oncodaily.com/insight/immu...

#AntiangiogenicAgents #Cancer #ImmuneBlockade #Health #NationalCancerInstitute #OncoDaily #Oncology #Medicine